Epidermal growth factor receptor and tumor response to radiation: In vivo preclinical studies

International Journal of Radiation Oncology Biology Physics

Volumn 58, Issue 3, 2004, Pages 966-971

  Milas, Luka ^a   Fan, Zhen ^a   Andratschke, Nicolaus H ^a   Ang, K Kian ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

C225; EGFR; Tumor radioresponse

Indexed keywords

CELLS; DNA; GROWTH KINETICS; MONOCLONAL ANTIBODIES; RADIOTHERAPY; SKIN; TOXICITY;

CYTOTOXICITY; RADIOCURABILITY;

TUMORS;

CETUXIMAB; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; MONOCLONAL ANTIBODY;

ADAPTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER RADIOTHERAPY; CANCER THERAPY; CARCINOMA; CHIMERA; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA TRANSFECTION; IN VIVO STUDY; MOLECULAR CLONING; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION INJURY; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; TUMOR XENOGRAFT; WESTERN BLOTTING;

EID: 1242270605     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.08.035     Document Type: Conference Paper

References (24)

1. Yarden Y., Sliwkowski M.X. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2:2001;127-137.
2. Milas L., Fan Z., Mason K.A., Ang K.K. Role of epidermal growth factor receptor (EGFR) and its inhibition in radiotherapy. Nieder C., Milas L., Ang K.K. Modification of radiation response. 2002;189-201 Springer-Verlag, Heidelberg, Germany.
3. Mendelsohn J., Fan Z. Epidermal growth factor receptor family and chemosensitization. J Natl Cancer Inst. 89:1997;341-343.
4. Wikstrand C.J., Bigner D.D. Prognostic applications of the epidermal growth factor receptor and its ligand, transforming growth factor-α J Natl Cancer Inst. 90:1998;799-801.
5. Grandis J.R., Melham M.F., Gooding W.E., et al. Levels of TGF-α and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst. 90:1998;824-832.
6. Sheridan M.T., O'Dwyer T., Seymour C.B., et al. Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neck. Radiat Oncol Invest. 5:1997;180-186.
7. Akimoto T., Hunter N.R., Buchmiller L., et al. Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas. Clin Cancer Res. 5:1999;437-443.
8. Milas L., Akimoto T., Hunter N.R., et al. Relationship between cyclin D1 expression and poor radioresponse of murine carcinomas. Int J Radiat Oncol Biol Phys. 52:2002;514-521.
9. Ang K.K., Berkey B.A., Tu X., et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res. 62:2002;7350-7356.
10. Liang K., Ang K.K., Milas L., et al. The epidermal growth factor receptor mediates radioresistance. Int J Radiat Oncol Biol Phys. 53:2003;246-254.
11. Balaban N., Moni J., Shannon M., et al. The effect of ionizing radiation on signal transduction Antibodies to EGF receptor sensitize A431 cells to radiation . Biochim Biophys Acta. 1314:1996;147-156.
12. Schmidt-Ullrich R.K., Valerie K., Fogleman P.B., et al. Radiation-induced autophosphorylation of epidermal growth factor receptor in human malignant mammary and squamous epithelial cells. Radiat Res. 145:1996;81-85.
13. Schmidt-Ullrich R.K., Mikkelsen R.B., Dent P., et al. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene. 15:1997;1191-1197.
14. Goldkorn T., Balaban N., Shannon M., et al. EGF receptor phosphorylation is affected by ionizing radiation. Biochim Biophys Acta. 1358:1997;289-299.
15. Carter S., Auer K.L., Reardon D.B., et al. Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose radiation in A431 human squamous carcinoma cells. Oncogene. 16:1998;2787-2796.
16. Bowers G., Reardon D., Hewitt T., et al. The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells. Oncogene. 20:2001;1388-1397.
17. Reardon D.B., Contessa J.N., Mikkelsen R.B., et al. Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells. Oncogene. 18:1999;4756-4766.
18. Milas L., Mason K., Hunter N., et al. In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody. Clin Cancer Res. 6:2000;701-708.
19. Nasu S., Ang K.K., Fan Z., et al. C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability. Int J Radiat Oncol Biol Phys. 51:2001;474-477.
20. Bianco C., Bianco R., Tortora G., et al. Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide. Clin Cancer Res. 6:2000;4343-4350.
21. Huang S.-M., Bock J.M., Harari P.M. Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck. Cancer Res. 59:1999;1935-1940.
22. Huang S.M., Harari P.M. Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis . Clin Cancer Res. 6:2000;2166-2174.
23. Bandyopadhyay D., Mandal M., Adam L., et al. Physical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cells. J Biol Chem. 273:1998;1568-1573.
24. Ang KK, Andratschke NH, Milas L. Epidermal growth factor receptor and response of human head-and-neck carcinoma to therapy. Int J Radiat Oncol Biol Phys 2004;58:959-965.